NASHVILLE, Tenn. / Oct 04, 2023 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast:
What: | HCA Healthcare, Inc. 3Q Earnings Release Call | ||
When: | Tuesday, October 24, 2023 at 9:00 am central (10:00 am eastern) | ||
How: | Live Audio over the Internet: | ||
CLICK HERE TO REGISTER | |||
Contact:
Frank Morgan, 615-344-2688, Vice President, Investor Relations, This email address is being protected from spambots. You need JavaScript enabled to view it.
If you are unable to listen during the live webcast, the call will be archived on the web site https://investor.hcahealthcare.com/events-and-presentations/default.aspx.
| Last Trade: | US$481.06 |
| Daily Change: | 2.92 0.61 |
| Daily Volume: | 1,190,315 |
| Market Cap: | US$109.770B |
October 31, 2025 October 27, 2025 October 24, 2025 August 27, 2025 | |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORE
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
